Address: Representation of Berlin-Chemie for Ukraine
29, Bereznyakivska st.
02098 Kiev
Ukraine
Tel: +38 044 494 33 88
Web: http://www.en.berlin-chemie.ua/
BERLIN-CHEMIE develops, produces and sells pharmaceutical products.
The representative office BERLIN-CHEMIE Ukraine acts on behalf of BERLIN-CHEMIE, a subsidiary of the MENARINI Group, in Ukraine. The MENARINI group has occupied a leading position in the Italian pharmaceutical market for many years. Formed in 1886 and headquartered in Florence, the MENARINI company was developed over the generations to become a global, owner-managed pharmaceutical company.
Analgesics and antiinflammatory drugs, Antidiabetics, Cardiovascular agents, Gastrointestinal agents, Thyroid therapeutic agents, Clinical nutrition, solutions for infusion.
Following Takeda’s acquisition of Nycomed earlier this year, how has the transaction affected your operations in Ukraine and what synergies were generated by it? Regarding the integration process, we are…
As the founder of SMD what was it the prompted you to create this company and what were your objectives at that time? Up until 2003 when I created SMD,…
What was the market need that spawned the creation of AIPM in 2009 considering that there were already other trade associations in Ukraine that were representing the interests of international…
Lekhim group was one of the pioneers for establishing a national pharmaceutical industry in 1992. This year you will be celebrating 20th anniversary. Would you start by providing us with…
If you could provide our readers with your philosophy when you founded Sayenko Kharenko in 2004. What were the market needs that were perhaps missing that you identified and wanted…
It has been one year since you were appointed as the head of UCB’s operations in Ukraine. What was the mission of your assignment when you took this position and…
Considering you only took over as CEO from your father in 2009, what was the mandate that was given to you as new CEO of the company – including your…
Orion’s global strategy focuses on the CIS and Eastern European markets that still exhibit large growth potential and are expanding, despite a reverse trend for the rest of the industry.…
What were the factors that led to Sanofi’s decision to establish an LLC in 2009 in Ukraine, and how has it changed your operations? Most of the major foreign companies…
Ipsen has showed some very positive results worldwide in 2010 and so far this year, specifically in non-Western European markets that grew by 12% in 2010. How have the Ukrainian…
Since the establishment of Astellas’ predecessor Brocade in Russia in 1992, what has been Astellas’ evolution in Ukraine? Astellas has been present in Ukraine for 16 years, first as Yamanouchi…
See our Cookie Privacy Policy Here
